68 participants
REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2023-09-06
- Start Date:
- 2015-08-28
- Completion:
- 2021-09-19
Conditions
- Ovarian Carcinoma
Interventions
- DRUG
No Results Yet